John M. Leonard, President and CEO at Intellia Therapeutics, Inc. (NTLA), sold 34,146 shares at $9.21 ($314K) on 2026-01-05, disclosed to the SEC on 2026-01-07.
Seasonal sale ($314k) by President and CEO — this insider has traded NTLA in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| NTLA | SELL | 2025-01-07 | $653K | — | Filing → |
| NTLA | SELL | 2024-01-05 | $1.1M | — | Filing → |
| NTLA | SELL | 2023-01-06 | $497K | — | Filing → |